Dear Colleagues,
On behalf of the Organizing Committee, we are delighted to welcome you to the 3rd Asian Conference on Innovative Therapies and New Technologies for Diabetes Prevention and Management (ATTD-ASIA 2026), which will take place from December 9–11, 2026, in Kyoto, Japan.
Following the continued success and growing impact of ATTD-ASIA, the Conference remains committed to advancing diabetes care throughout the region and beyond. We are excited to invite you to join us for this significant event that will bring together leading experts from across the globe.
ATTD-ASIA 2026 will offer 2.5 days of dynamic collaboration and innovation, uniting clinicians, researchers, diabetes care providers, industry partners, as well as key stakeholders from industry, including pharmaceutical and medical technology companies, investors, reimbursement authorities, and regulators, and people with diabetes.
As leaders and innovators in the field, your contribution is essential. ATTD-ASIA 2026 will serve as a unique platform for knowledge exchange, scientific dialogue, cross-sector partnership, and forward-looking discussions between academia, clinical practice, and industry. The program will feature engaging presentations on cutting-edge developments, including advances in artificial intelligence applied to diabetes care, glucose sensors, closed-loop systems, novel pharmacologic therapies, and emerging treatment strategies, delivered by world-renowned experts.
We are honored to host ATTD-ASIA 2026 in Kyoto, a city that will provide an exceptional setting for a transformative scientific and clinical experience.
We look forward to welcoming you in Kyoto as we continue to push the boundaries of diabetes management and improve the lives of people living with diabetes.
Yours sincerely,
Professor Moshe Phillip & Professor Tadej Battelino
Conference Chairpersons
